Incidence and Management of Elevated Intraocular Pressure with Antivascular Endothelial Growth Factor Agents

Author： Abedi Gelareh   Adelman Ron A.   Salim Sarwat  

Publisher： Informa Healthcare

ISSN： 0882-0538

Source： Seminars in Ophthalmology, Vol.28, Iss.3, 2013-05, pp. : 126-130

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intraocular Pressure in Eyes Receiving Intravitreal Antivascular Endothelial Growth Factor Injections

By  

Ophthalmologica, Vol. 233, Iss. 3-4, 2015-03 ,pp. : 162-168

Karger

Access to resources Recommend Favorite

Short-Term Visual Acuity and Intraocular Pressure Changes and Their Correlation after Anti-Vascular Endothelial Growth Factor Injection

By  

Ophthalmologica, Vol. 236, Iss. 1, 2016-04 ,pp. : 36-42

Karger

Access to resources Recommend Favorite

Comparative Analysis of Hyaluronan’s Affinity for Antivascular Endothelial Growth Factor Agents

By  

Ophthalmic Research, Vol. 49, Iss. 1, 2012-10 ,pp. : 43-48

Karger

Access to resources Recommend Favorite

Evaluation of the Incidence of Endophthalmitis after Intravitreal Injection of Anti-Vascular Endothelial Growth Factor

By  

Ophthalmologica, Vol. 226, Iss. 3, 2011-07 ,pp. : 145-150

Karger

Access to resources Recommend Favorite

Anti-Vascular Endothelial Growth Factor Treatment for Retinal Vein Occlusions

By  

Ophthalmologica, Vol. 227, Iss. 1, 2012-04 ,pp. : 30-35

Karger

Access to resources Recommend Favorite